Continuing Business Relationship. The Company and Dr. Finer hereby acknowledge and agree that (i) Dr. Finer has continuously served as a member of the Board of Directors of the Company (a “Director”) since October 16, 2017 and continues to serve as a Director; (ii)
Appears in 3 contracts
Sources: Consulting Agreement, Consulting Agreement (Tcr2 Therapeutics Inc.), Consulting Agreement (Tcr2 Therapeutics Inc.)